Can ethanol therapies injure the bile ducts?

Hepato-Gastroenterology

Volumn 50, Issue 49, 2003, Pages 69-72

  Koniaris, Leonidas G ^a,b   Seibel, Jeffrey A ^a   Geschwind, Jean Francois ^a   Sitzmann, James V ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Embolization; Ethanol; Hepatocellular carcinoma; Liver; Percutaneous

Indexed keywords

ALCOHOL; CONTRAST MEDIUM; DISOFENIN; POLYVINYL ALCOHOL SPONGE; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT INJURY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEMANGIOMA; HEPATIC ARTERY; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; INTERVENTIONAL RADIOLOGY; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER RESECTION; LIVER TUMOR; PRIORITY JOURNAL;

ADULT; BILE DUCTS; CHOLANGIOGRAPHY; EMBOLIZATION, THERAPEUTIC; ETHANOL; FEMALE; HEMANGIOMA; HUMANS; LIVER NEOPLASMS; SOLVENTS;

EID: 0037266557     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Livraghi T, Giorgio A, Marin G, Salmi A, Sio I, Bolondi L, Pompili M, et al: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
2. Ryu M, Shimamura Y, Kinoshita T, Konishi M, Kawano N, Iwasaki M, Furuse J, et al: Therapeutic results of resection, transcatheter arterial embolization, and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997; 27:251-257.
3. Giorgio A, Tarantino L, Mariniello N, de Stefano G, Perrotta A, Aloisio V, Voza A, et al: Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 year survival in 112 patients. Eur J Ultrasound 1998; 8:201-206.
4. Wallace S, Charnsangavej C, Carrasco CH, Bechtel W: Ethanol for hepatic artery embolization. Radiology 1984; 152:821-2.
5. Yamakado K, Nakatsuka A, Tanaka N, Matsumura K, Takase K, Takeda K: Long-term follow-up arterial chemoembolization combined with transportal ethanol injection used to treat hepatocellular carcinoma. JVIR 1999; 10:641-647.
6. Carrasco CH, Chuang VP, Wallace S: Apudomas metastatic to the liver: treatment by hepatic artery embolization. Radiology 1983; 149:79-83.
7. Yakes WF, Luethke JM, Parker SH, Stavros AT, Rak KM, Hopper KD, Dreisbach JN, et al: Ethanol embolization of vascular embolizations. Radiographics 1990; 10:787-796.
8. Ogasawara K, Uchino J, Une Y, Fujioka Y: Selective portal vein embolization with absolute ethanol induces hepatic hypertrophy and makes more extensive hepatectomy possible. Hepatology 1996; 23:338-345.
9. Shimamura T, Nakajima Y, Une Y, Namieno T, Ogasawara K, Yamashita K, Haneda T, et al: Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery 1997; 121:135-141.
10. Coldwell DM, Stokes KR, Yakes WF: Embolotherapy: agents, clinical applications, and techniques. Radiographics 1994; 14:623-643.
11. Ludwig J, Kim CH, Wiesner RH, Krom RA: Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology 1988; 9:215-218.
12. Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, Saito S, et al: The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998; 82:78-85.
13. Doppman JL, Girton ME. Bile duct scarring following ethanol embolization of the hepatic artery: an experimental study in monkeys. Radiology 1984; 152:621-626.
14. Matsui O, Kawamura I, Kadoya M, Takashima T, Nakanuma Y: Hepatic embolization of experimental hepatic tumors with absolute ethanol. Cardiovasc Intervent Radiol 1986; 9:146-151.
15. Koda M, Ooi S, Okamoto M, Ootsuki H, Nakazawa S, Yamanishi Y, Kawasaki H, et al: A hepatocellular carcinoma with intrahepatic bile duct dilation and right lobe atrophy following percutaneous ethanol injection therapy. Gan No Rinsho 1990; 36:2053-2058.
16. Koda M, Okamoto K, Miyoshi Y, Kawasaki H: Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma. Gastrointest Radiol 1992; 17:167-169.
17. Chan MK, Kwok PC, Chan SC, Lam TW, Lo KK, Lam CL: Percutaneous ethanol injection as a possible curative treatment foe malignant portal vein thrombosis in hepatocellular carcinoma. Cardiovasc Intervent Radiol 1999; 22:326-328.
18. Polo JR, Garcia-Sabrido JL: Sclerosing cholangitis associated with hydatid liver disease. Arch Surg 1989; 124:637.
19. Gelczer RK, Charboneau JW, Hussain S, Brown DL: Complications of percutaneous ethanol ablation. J Ultrasound Med 1998; 17:531-533.
20. Ishii H, Okada S, Okusaka T, Yoshimori M, Nakasuka H, Shimada K, Yamasaki S, et al: Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1998; 82:1638-1642.
21. Latshaw RF, Pearlman RL, Schaitkin BM, Griffith JW, Weidner WA: Intraarterial ethanol as a long-term occlusive agent in renal, hepatic, and gastrosplenic arteries of pigs. Cardiovasc Intervent Radial 1985; 8:24-30.
22. O'Riodan D, McAllister H, Sheahan BJ, MacErlean DP: Hepatic infarction with absolute ethanol. Radiology 1984; 152:627-630.
23. Castellano G, Moreno-Sanchez D, Gutierrez J, Moreno-Gonzalez E, Colina F, Solis-Herruzo JA: Caustic sclerosing cholangitis. Report of four cases and a cumulative review of the literature. Hepatogastroenterology 1994; 41:458-470.